These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19516243)

  • 1. Association between repeat hospitalization and early intervention in dialysis patients following hospital discharge.
    Chan KE; Lazarus JM; Wingard RL; Hakim RM
    Kidney Int; 2009 Aug; 76(3):331-41. PubMed ID: 19516243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing repeat hospitalizations in dialysis patients: a call for action.
    Plantinga LC; Jaar BG
    Kidney Int; 2009 Aug; 76(3):249-51. PubMed ID: 19904257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anemia, hospitalization, and mortality in patients receiving peritoneal dialysis in the United States.
    Li S; Foley RN; Collins AJ
    Kidney Int; 2004 May; 65(5):1864-9. PubMed ID: 15086928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RightReturn. Partnering to reduce the high rate of hospital readmission for dialysis-dependent patients.
    Wingard RL; Chan KE; Hakim R
    Nephrol News Issues; 2012 Mar; 26(3):20-2. PubMed ID: 22479972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anemia management and association of race with mortality and hospitalization in a large not-for-profit dialysis organization.
    Servilla KS; Singh AK; Hunt WC; Harford AM; Miskulin D; Meyer KB; Bedrick EJ; Rohrscheib MR; Tzamaloukas AH; Johnson HK; Zager PG
    Am J Kidney Dis; 2009 Sep; 54(3):498-510. PubMed ID: 19628315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron-replete hemodialysis patients do not require higher EPO dosages when converting from subcutaneous to intravenous administration: results of the Italian Study on Erythropoietin Converting (ISEC).
    Pizzarelli F; David S; Sala P; Icardi A; Casani A
    Am J Kidney Dis; 2006 Jun; 47(6):1027-35. PubMed ID: 16731298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in anemia management and hemoglobin levels following revision of a bundling policy to incorporate recombinant human erythropoietin.
    Hasegawa T; Bragg-Gresham JL; Pisoni RL; Robinson BM; Fukuhara S; Akiba T; Saito A; Kurokawa K; Akizawa T
    Kidney Int; 2011 Feb; 79(3):340-6. PubMed ID: 20962740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The "right" of passage: surviving the first year of dialysis.
    Wingard RL; Chan KE; Lazarus JM; Hakim RM
    Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S114-20. PubMed ID: 19995993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perihospitalization patterns of hemoglobin levels and erythropoiesis-stimulating agent doses in US hemodialysis patients, 1998-2009.
    Foley RN; Solid CA; Lamb K
    Hemodial Int; 2014 Jan; 18(1):24-31. PubMed ID: 24131588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher doses of erythropoietin-stimulating agents and hyporesponsiveness to their effects are associated with increased mortality among prevalent hemodialysis patients.
    Nishio A; Chhatkuli BP; Ma JZ; Kalantari K
    Blood Purif; 2013; 36(1):29-36. PubMed ID: 23735569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A hematocrit greater than 36 lessens mortality and hospitalization in hemodialysis].
    Fernández-Gallego J; Gutiérrez C
    Nefrologia; 2003; 23(2):177-8. PubMed ID: 12778885
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of high-flux hemodialysis on renal anemia.
    Ayli D; Ayli M; Azak A; Yüksel C; Kosmaz GP; Atilgan G; Dede F; Abayli E; Camlibel M
    J Nephrol; 2004; 17(5):701-6. PubMed ID: 15593038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting anemia management in hemodialysis patients: a single-center experience.
    Spiegel DM; Gitlin M; Mayne T
    Hemodial Int; 2008 Jul; 12(3):336-41. PubMed ID: 18638090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Erythropoietin and transfusions in patients with anemia of chronic renal failure origin : an update view].
    Duclos J; Olea C; Aguirre H; Alvarez MC; Salgado MC
    Rev Med Chil; 1995 Apr; 123(4):451-5. PubMed ID: 8525189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How do disorders related to hospitalisation influence haemodialysis patients' nutrition?
    Borrego Utiel FJ; Segura Torres P; Pérez del Barrio MP; Sánchez Perales MC; García Cortés MJ; Serrano Angeles P; Biechy Baldan MM; Liébana Cañada A
    Nefrologia; 2011; 31(4):471-83. PubMed ID: 21738250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of acute kidney injury in the critically ill and postdischarge outcomes: a cohort study*.
    Horkan CM; Purtle SW; Mendu ML; Moromizato T; Gibbons FK; Christopher KB
    Crit Care Med; 2015 Feb; 43(2):354-64. PubMed ID: 25474534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
    Ifudu O; Feldman J; Friedman EA
    N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of a change in erythropoiesis-stimulating agent dose during hospitalization and subsequent hemoglobin levels and transfusions in hemodialysis patients.
    Wong BC; Ravani P; Manns BJ; Lewin A; Zhang X; Chin R; Hemmelgarn BR; Tonelli M; Oliver MJ; Quinn RR
    Am J Kidney Dis; 2013 Nov; 62(5):947-52. PubMed ID: 23856380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A trial of subcutaneous administration of darbepoetin alfa once every other week for the treatment of anemia in peritoneal dialysis patients.
    Mahajan S; Boulton H; Gokal R
    J Nephrol; 2004; 17(5):687-92. PubMed ID: 15593036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.